Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor

Metabolic abnormalities are common in cancers, and targeting metabolism is emerging as a novel therapeutic approach to cancer management. Pituitary adenoma (PA) is a type of benign tumor. Impairment of tumor cells’ metabolism in PA seems not to be as apparent as that of other malignant tumor cells;...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xin, Li, Song, Zhang, Wei-hua, Yang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531036/
https://www.ncbi.nlm.nih.gov/pubmed/26347444
http://dx.doi.org/10.2147/DMSO.S86319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531036/
https://www.ncbi.nlm.nih.gov/pubmed/26347444
http://dx.doi.org/10.2147/DMSO.S86319

Ejemplares similares